发明名称 METHODS AND COMPOSITIONS FOR THE TARGETED MODIFICATION OF A GENOME
摘要 Compositions and methods are provided for modifying a genomic locus of interest in a eukaryotic cell, a mammalian cell, a human cell or a non-human mammalian cell using a large targeting vector (LTVEC) comprising various endogenous or exogenous nucleic acid sequences as described herein. Further methods combine the use of the LTVEC with a CRISPR/Cas system. Compositions and methods for generating a genetically modified non-human animal comprising one or more targeted genetic modifications in their germline are also provided.
申请公布号 US2015159175(A1) 申请公布日期 2015.06.11
申请号 US201414578291 申请日期 2014.12.19
申请人 Regeneron Pharmaceutical, Inc. 发明人 Frendewey David;Auerbach Wojtek;Lai Ka-Man Venus;Mujica Alexander O.;Lee Jeffrey D.;Droguett Gustavo;Trzaska Sean;Hunt Charleen;Gagliardi Anthony;Kuno Junko;Valenzuela David M.;Yancopoulos George D.
分类号 C12N15/90 主分类号 C12N15/90
代理机构 代理人
主权项 1. A method for modifying a genome in a mouse cell or a human cell at a genomic locus of interest, comprising contacting the genome with a Cas protein, a CRISPR RNA that hybridizes to a CRISPR target sequence at the genomic locus of interest, and a tracrRNA, wherein the genome is contacted in the presence of a large targeting vector (LTVEC) that is at least 10 kb and comprises an insert nucleic acid flanked with: (i) a 5′ homology arm that is homologous to a 5′ target sequence at the genomic locus of interest; and(ii) a 3′ homology arm that is homologous to a 3′ target sequence at the genomic locus of interest, wherein the insert nucleic acid is at least 30 kb and/or the 5′ target sequence and the 3′ target sequence are separated by at least 30 kb; wherein following contacting with the Cas protein, CRISPR RNA, and tracrRNA in the presence of the LTVEC, the genome comprises a targeted genetic modification at the genomic locus of interest, wherein the modified genomic locus of interest comprises the insert nucleic acid.
地址 Tarrytown NY US